Session 1:

A 50-year history of cancer clinical research

Chairs: S. Garattini & F. Meunier

09:30 - 09:55
Opening ceremony - A FILM
09:55 - 10:00
Welcoming address
Françoise Meunier
10:00 - 10:10
Message from HRH Princess Astrid of Belgium
HRH Princess Astrid of Belgium
10:10 - 10:30
The challenges of the EORTC after half a century
Jean-Yves Blay
10:30 - 10:40
EORTC Charitable Trust : The challenges of funding academic research
Christopher Mallaby
10:40 - 11:00
Patient voice: The vision for the 21st century
Peter Kapitein
11:00 - 11:30
Coffee Break

Session 2:

A Pan-European collaboration

Chairs: D. Van Bekkum & G. McVie

11:30 - 11:50
The European Commission vision for Pan-European academic clinical research
Ruxandra Draghia-Akli
11:50 - 12:10
European Cooperation: Dream - Reality - Necessity
Françoise Meunier
12:10 - 12:45
Henri Tagnon lecture: The changing paradigms for melanoma care and research
Alexander Eggermont
12:45 - 14:00
Lunch

Session 3:

Achievements and trials that changed medical practice

Chairs: U. Veronesi & L. Denis (14.00-16.00), JC. Horiot & J. Jassem (16.30-18.10)

14:00 - 14:40
Research in surgical oncology: Lessons from the past and less is more
Emiel Rutgers
14:40 - 15:20
From radiation-therapy to radiation-oncology: A 50-year EORTC contribution
Jean-Claude Horiot
15:20 - 16:00
Clinical research in medical oncology: The patient, the tumor, the target and the drug
Patrick Schöffski
16:00 - 16:30
Coffee Break
16:30 - 17:30
PROGRESS IN HAEMATOLOGY:

Adult Leukemia
Jean-Pierre Marie

Children Leukemia
Yves Benoit

Lymphoma
Michel Henry-Amar

 

17:30 - 17:50
50 years of management of febrile neutropenia
Peter Donnelly
17:50 - 18:10
EORTC research in quality of life
Galina Velikova
18:10 - 22:00
Evening Event at the Magritte Museum (private visit and walking dinner)

Session 4:

Integrating biology in novel clinical trials

Chairs: N. Harbeck & A. van Oosterom

09:00 - 09:20
IMI and cancer research
Michel Goldman
09:20 - 09:40
Translational research in brain tumors
Monika Hegi
09:40 - 10:00
The need for new concepts in clinical trials: The role of NOCI & the MINDACT example
Martine Piccart
10:00 - 10:20
Adapting the EORTC Headquarters to the rapidly changing environment
Denis Lacombe
10:20 - 10:50
Coffee Break

Session 5:

Future challenges and perspectives

Chairs: M. Piccart & A. Eggermont

10:50 - 11:20
The economics of innovative cancer treatments and policy implications
Koen Torfs
11:20 - 11:50
Functional Imaging as a surrogate endpoint for clinical efficacy
Lalitha Shankar
11:50 - 12:20
Methodology, response to treatment and RECIST
Jan Bogaerts
12:20 - 12:45
Prerequisites for making translational research an essential component of EORTC trials
Nadia Harbeck
12:45 - 13:15
The path forward
Roger Stupp